The company adheres to an innovation-driven strategy, is committed to addressing unmet clinical needs and continuously promoting drug accessibility. Focusing on tumors, cardiovascular diseases, neurological diseases, autoimmune diseases, and rare diseases, the company has established a series of competitive innovative drug R&D pipelines, which are based on several cutting-edge technology platforms.
Proportion of R&D investment
On-going research projects (incl. both innovative and high-value projects)
Professionals in R&D and Clinical Medicine
Proportion of R&D team with master and PhD
Four R&D Directions
Characteristic API
High-end generic drugs
Innovative drugs
Novel drug delivery system
Focused Disease Areas:
Tumors
Cardiovascular Diseases
Neurological Diseases
Autoimmune Diseases
Rare Diseases
Key R&D Institutions
Pharmaceutical Research Institute
Purity Research Institute
ScinnoHub Pharmaceuticals
Shanghai Hongcheng Biopharma
Brilliant Harpoon Biotechnology
Haihe Pharmaceuticals
Suvanta Pharma
R&D Innovation Features
Differentiated Pipelines
International R&D Team
Scientific and Precise Project Initiations
Diversified Cooperation Models
Four R&D Directions
Characteristic API
High-end generic drugs
Innovative drugs
Novel drug delivery system
Focused Disease Areas:
Tumors
Cardiovascular Diseases
Neurological Diseases
Autoimmune Diseases
Rare Diseases
Key R&D Institutions
Pharmaceutical Research Institute
Purity Research Institute
ScinnoHub Pharmaceuticals
Shanghai Hongcheng Biopharma
Brilliant Harpoon Biotechnology
Haihe Pharmaceuticals
Suvanta Pharma
R&D Innovation Features
Differentiated Pipelines
International R&D Team
Scientific and Precise Project Initiations
Diversified Cooperation Models
Technology Platforms
R&D Institutions
Pharmaceutical Research Institute
Purity Research Institute
ScinnoHub Pharmaceuticals
Shanghai Hongcheng Biopharma
Brilliant Harpoon Biotechnology
Haihe Pharmaceuticals
Suvanta Pharma Inc.
R&D Talents
The company values the introduction and cultivation of innovative talent, has a well-established talent incentive mechanism, and integrates talent development with its strategic direction in science and technology to enable them to fully exercise their innovative abilities and meet the needs of the company, the industry, and society
Intellectual Property
Patent Applications
Domestic Authorized Patents
Overseas Patent Applications
Overseas Authorized Patents
